Učitavanje...

5-ALA-guided resection of glioblastoma: a single-centre, retrospective analysis of progression pattern and survival

INTRODUCTION: The EORTC-NCIC trial in glioblastoma showed a median overall survival (OS) rate of 14.6 months following resection and chemoradiotherapy. This poor prognosis is attributed to early invasion and almost inevitable progression with failure to achieve local control. However, improvement in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Senthil, Keerthi, Piper, Rory J, Sage, William, Sinha, Rohit, Jena, Raj, Price, Stephen
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791633/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox238.085
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!